Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001074569 | SCV001240160 | pathogenic | Retinal dystrophy | 2018-12-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001377780 | SCV001575203 | pathogenic | Retinitis pigmentosa 12; Leber congenital amaurosis 8 | 2023-12-28 | criteria provided, single submitter | clinical testing | This sequence change replaces cysteine, which is neutral and slightly polar, with tyrosine, which is neutral and polar, at codon 152 of the CRB1 protein (p.Cys152Tyr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Leber congenital amaurosis (PMID: 23449718, 25356976). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 812296). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CRB1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV003455044 | SCV004178821 | likely pathogenic | Leber congenital amaurosis 8 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003455043 | SCV004178822 | likely pathogenic | Retinitis pigmentosa 12 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Sharon lab, |
RCV001002988 | SCV001161042 | likely pathogenic | Leber congenital amaurosis | 2019-06-23 | no assertion criteria provided | research |